Evidence map›Paper›PMID 35460177›Full record

ArticleThoracic cancer2022

Usefulness of positron-emission tomography for predicting the World Health Organization grade of thymic epithelial tumors.

Takashi Kanou, Soichiro Funaki, Masato Minami, Naoko Ose, Toru Kimura, Eriko Fukui, Tadashi Watabe, Yasushi Shintani

Abstract read
In one paragraph

Article in Thoracic cancer, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Takashi KanouDepartment of General Thoracic Surgery, Osaka University Graduate School of Medicine, Osaka, Japan.ORCID 0000-0003-2955-1490
Soichiro FunakiDepartment of General Thoracic Surgery, Osaka University Graduate School of Medicine, Osaka, Japan.
Masato MinamiDepartment of General Thoracic Surgery, Osaka University Graduate School of Medicine, Osaka, Japan.
Naoko OseDepartment of General Thoracic Surgery, Osaka University Graduate School of Medicine, Osaka, Japan.
Toru KimuraDepartment of General Thoracic Surgery, Osaka University Graduate School of Medicine, Osaka, Japan.
Eriko FukuiDepartment of General Thoracic Surgery, Osaka University Graduate School of Medicine, Osaka, Japan.
Tadashi WatabeDepartment of Nuclear Medicine and Tracer Kinetics, Osaka University Graduate School of Medicine, Osaka, Japan.
Yasushi ShintaniDepartment of General Thoracic Surgery, Osaka University Graduate School of Medicine, Osaka, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIt is often difficult to distinguish between thymoma and thymic carcinoma by preoperative radiological tests. While there have been some reports that the maximum standardized uptake value (SUV

methodsFrom 2011 to 2019, 129 patients with thymic epithelial tumor who underwent PET-CT before surgical treatment were enrolled. The relevance of the SUV

resultsA total of 99 thymoma cases and 30 thymic carcinoma cases were enrolled into the study. The SUV

conclusionsPET-CT might provide significant information for differentiating images of thymoma and thymic carcinoma. We experienced several cases of thymic carcinoma with a moderate SUV

Indexed as

Neoplasms, Glandular and EpithelialThymomaThymus NeoplasmsFluorodeoxyglucose F18HumansPositron-Emission TomographyPositron Emission Tomography Computed TomographyRetrospective StudiesWorld Health OrganizationFluorodeoxyglucose F18pathologyPET-CTradiological diagnosisthymic epithelial tumor

Identifiers

PMID35460177
PMCPMC9161332

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.